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Variations of dry eye disease prevalence by age, 
sex and geographic characteristics in China:  
a systematic review and meta-analysis
Background Dry eye disease (DED) is one of the most prevalent ocular dis-
eases in the world. In China, new lifestyles driven by information technol-
ogy and the rapid ageing process have brought DED a severe public health 
concern. The aim of our study was to obtain the pooled prevalence of DED 
in China and explore its potential correlates.
Methods A comprehensive systematic review was conducted to identify all 
relevant literature published since 1990. Meta-analysis and meta-regression 
approaches were adopted to estimate the prevalence of DED. The number 
of people with DED was obtained by multiplying the corresponding demo-
graphic data in 2010.
Results Advanced age, female sex and larger latitude were significant risk 
factors for DED by symptoms and signs, whereas only advanced age was 
positively associated with an increased prevalence of DED by symptoms. 
In 2010, the prevalence of DED by symptoms and signs were 13.55% 
(95% CI = 10.00-18.05) and that of DED by symptoms was 31.40% (95% 
CI = 23.02-41.13) in Chinese people aged 5-89 years, corresponding to a 
total of 170.09 million (95% CI = 125.52-226.63) and 394.13 million (95% 
CI = 288.99-516.30) affected individuals respectively.
Conclusions The huge burden of DED in China calls for more public health 
attention and actions. Improved epidemiological studies on DED prevalence 
are still urgently needed.
Electronic supplementary material: 
The online version of this article contains supplementary material.
journal of
health
global
Dry eye disease (DED), a multifactorial tear deficiency disorder of the ocular 
surface, is one of the most prevalent ocular diseases in the world [1-3]. In daily 
ophthalmological practice, DED is a frequently encountered ocular problem, it is 
characterised by different combinations of excessive tear evaporation, decreased 
tear production and poor tear quality [3,4]. Affected individuals are generally 
plagued by various symptoms, such as photophobia, fatigue, itchiness, burning, 
irritation and visual disturbance [1,5]. Although these debilitating symptoms 
do not lead to severe visual impairment and blindness, they are highly related 
to the reduction in vision-related quality of life and interfere with daily activ-
ities [6-8]. Furthermore, the limited ability to produce tears may result in an 
increased risk of ocular infection and ocular surface damage, or even abrasion 
or corneal ulceration in severe cases [5,9].
There is still no gold diagnostic procedure of DED [9,10], and the treatment of 
DED is only a temporarily symptomatic relief and improvement [3,9]. Common 
symptom-based questionnaires include the Ocular Surface Disease Index and 
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the Dry Eye Questionnaire [1]. In addition to symptoms, signs are also essential components in virtual-
ly all the definitions of DED, common tests of DED include the Schirmer’s I test (SIt), tear film breakup 
time (TBUT), fluorescein staining (FS) of the cornea and conjunctiva [11]. Previous epidemiological ev-
idence has revealed an overall DED prevalence of 5% to as high as 50% in general population across the 
world, the large variation may come from the disparities of diagnostic criteria, as well as characteristics 
of the investigated population and etiological factors [4,12-17]. Important risk factors for DED were also 
identified, including advanced age, female sex, use of exogenous oestrogen and visual display terminals 
(VDTs) [1,12,13,18-20]. Other environmental factors, such as low relative humidity, have also been sug-
gested as probable contributors of DED but still need further validation [1,21].
According to the 2017 report of the Tear Film and Ocular Surface Society (TFOS) Dry Eye Workshop 
(DEWS) Epidemiology subcommittee, Asian race was suggested as a significant risk factor for DED [17]. 
For China, the largest developing country, new lifestyles driven by information technology and the rap-
id ageing process have brought DED a severe public health concern in both young and old generations 
[4,22,23]. The latest systematic review and meta-analysis of DED prevalence in China conducted by N 
Liu, et al. revealed a pooled DED prevalence of 17.0%, by using prevalence estimates from 12 individu-
al studies. However, two out of the 12 studies reported the prevalence of symptomatic DED, whereas 10 
reported the prevalence of DED diagnosed by both symptoms and signs [23]. Given the fact that studies 
based on symptom-diagnosis report higher prevalence rates of DED than those involved both symptoms 
and signs [15], it is reasonable to believe that their estimate of DED prevalence is problematic. Further-
more, the relation between patient-reported symptoms and clinical signs has been proven to be poor and 
inconsistent [24-26], it is, therefore, necessary to synthesise the DED prevalence in different diagnostic 
groups separately. In view of the geo-epidemiology of DED, the large geographical area of China provides 
a very good opportunity to explore the geographic variations of DED prevalence within the same country. 
In this study, we conducted a systematic review of the prevalence of DED, with a focus on the difference 
in diagnostic methods. To better understand the probable risk factors, we investigated the differences in 
prevalence by age, sex, setting and geographic factors.
METHODS
Search strategy and selection criteria
This study is in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analysis 
(PRISMA) guidelines [27]. No protocol for this systematic review was pre-registered. A comprehensive 
systematic review was conducted to identify all relevant literature published from January 01, 1990 to No-
vember 27, 2016. First, three Chinese and three English bibliographic databases, namely, Wanfang, China 
National Knowledge Infrastructure (CNKI), Chinese Biomedicine Literature Database (CBM-SinoMed), 
Medline, PubMed and Embase, were searched, the search terms included “prevalence” or “incidence” or 
“epidemiology” or “morbidity” or “mortality”, combined with “dry eye” and “China or Chinese”, in the 
forms of free words or controlled vocabulary (ie, medical subject headings). Different search languages and 
strategies were developed for different databases to adapt to their specific characteristics (Table S1 in On-
line Supplementary Document). No language restrictions were applied. Second, snowball searching was 
performed to further identify potentially relevant studies from the reference lists of articles in the first step.
All citations were independently reviewed by two researchers (MW and XC) in two stages: screening ti-
tles and abstracts followed by an appraisal of full-text articles. Criteria for inclusion were epidemiologi-
cal investigations of DED in general Chinese population. Studies that were conducted in subpopulations, 
such as people with specific diseases (eg, diabetes, hypertension, rheumatoid arthritis, lupus, Sjögren’s 
syndrome, thyroid associated diseases), were excluded because of their poor representativeness of gen-
eral population. All included studies should have a clear assessment and diagnostic method of DED. For 
multiple publications of the same study, the one with the most details was kept for further analysis.
Data extraction and quality assessment
The same two researchers (MW and XC) independently extracted the following information from the in-
cluded studies: study characteristics (eg, author[s], publication year, study design, assessment and diag-
nostic method, study site, study year), population characteristics (eg, age, sex) and the outcome measures 
(the number of participants and DED cases). For studies that reported prevalence in school children, we 
unified the age range of middle school students as 13-15 years, and high school students as 16-18 years 
Dry eye disease prevalence by age, sex and geographic characteristics in China
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according to the national education schemes [28]. The geographic information (latitude and longitude) 
of the investigation sites in all included studies was obtained by using the Google Maps GPS coordinates 
(http://www.gps-coordinates.net/).
In this study, DED was categorised into two diagnostic groups: “DED by symptoms and signs” and “DED 
by symptoms”, according to the diagnostic methods reported in individual studies. DED by symptoms 
and signs was defined as a positive symptom with at least one positive clinical sign tested by BUTS≤10s 
(5s) or SIt ≤10s (5s) or FS≥1 (2 or 3). Whereas DED by symptoms only replied on the presence of self-re-
ported positive symptoms. If more than one outcome measure were reported in different sub-groups (eg, 
different age or sex groups) within the same study, data were extracted for each subgroup separately. The 
quality of included studies was assessed according to the Reporting of Observational Studies in Epide-
miology (STROBE) guideline [29]. Sample population, sample size, participation rate, outcome assess-
ment, and analytical methods were assessed by scoring, with 0 for high risk and unclear, 1 for moderate 
risk and 2 for low risk. The total score of these five core components represented the overall bias risk of 
each study (Table S2 in Online Supplementary Document) [30,31]. Discrepancies at each step of both 
screening and data extraction were discussed and resolved with the help of a third independent research-
er (PS) until consensus was reached.
Statistical analysis
Prevalence of DED in each included study was calculated from the raw proportion and stabilised by us-
ing the logit transformation [32]. The heterogeneity between studies was tested by Cochran’s Q statistic 
(Q-test) and quantified by I2 index. A P < 0.05 in the Q-test indicates significant heterogeneity, and I2 in-
dex represents the percentage of between-study variance due to heterogeneity rather than chance, where 
values of 25% or less correspond to low heterogeneity, near 50% indicate moderate heterogeneity and 
near 75% or larger reflect high heterogeneity [33,34]. In the case of significant heterogeneity (P < 0.05 or 
I2>50%), a random-effects meta-analysis (DerSimonian and Laird method) was adopted to generate the 
pooled prevalence and 95% confidence intervals (CIs), otherwise, a Mantel-Haenszel fixed-effects mod-
el was adopted [35]. Leave-one-out sensitivity analysis was conducted to assess the robustness of the 
pooled results. Funnel plots were drawn to address publication bias visually, Begg’s rank correlation test 
and Egger’s linear regression were conducted to quantify the degree of publication bias [36,37].
The source of heterogeneity was explored by meta-regression. First, we did univariable meta-regression 
to test the individual association of prevalence estimates and relevant factors, which included age, sex 
(male vs female), setting (urban vs rural), study year and geographic indicators (latitude and longitude). 
Factors that were significantly associated with the prevalence of DED in the univariable meta-regression 
were subsequently included in the multivariable meta-regression analysis. To visually inspect the good-
ness of the final multivariable regression, diagnostic plots were generated, including predicted vs stan-
dardised residuals, Quantile-Quantile (QQ) plot and histogram of residuals.
Finally, based on the multivariable regression model, age and sex-specific prevalence of DED was cal-
culated for the whole country and six geographic regions (East China, North China, Northeast China, 
Northwest China, South Central China, Southwest China) (Figure S1 in Online Supplementary Docu-
ment) respectively. The number of people with DED in 2010 was calculated by multiplying the age and 
sex-specific DED prevalence with the corresponding population data obtained from the 6th national cen-
sus [38]. All analyses were performed using R, version 3.3.0 (R Foundation for Statistical Computing, Vi-
enna, Austria), the China map was obtained from the Global Administrative Areas database (GADM, 2015, 
version 2.0; www.gadm.org) and all maps were drawn by ArcMap version 10.1 (Environmental Systems 
Research Institute, Redlands, CA). A P < 0.05 indicated statistical significance and all P-values were 2-sided.
RESULTS
Search and selection results
A total of 2267 citations were identified by the primary search. After removing 1008 duplicates, the titles 
and abstracts of 1259 studies were screened for relevance. Then the full texts of 201 studies were assessed 
for eligibility, finally, 34 studies met the inclusion criteria, of which 21 reported the prevalence of DED 
by symptoms and signs, ten reported the prevalence of DED by symptoms and three reported both the 
prevalence of DED by symptoms and signs and that of DED by symptoms (Figure 1).
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Study characteristics and quality 
assessment
A summary of the main characteristics of the 34 
included studies is listed in Table 1, and the de-
tailed information can be found in Table S3 in 
Online Supplementary Document. 24 studies 
provided prevalence estimates of DED by symp-
toms and signs, where a total of 10113 individu-
als were identified as DED patients by symptoms 
and signs out of 65959 participants. All the 24 
studies were published in this century, with the 
majority being published in the last seven years 
(2010-2016) (n = 19, 79.17%), half being con-
ducted in urban areas (n = 12, 50%) and most 
providing prevalence for both males and females 
(n = 23, 95.83%).
In the 13 studies that provided prevalence es-
timates of DED by symptoms, a total of 28277 
participants were included, among whom 8955 
were with DED symptoms. More than half of 
the studies were published during 2000 to 2010 
(n = 7, 53.85%), mainly from mixed areas (rural 
and urban together) (n = 9, 69.23%), and report-
ed prevalence for both males and females (n = 11, 
84.62%).
All studies were rated with assessment scores of 
at least 6. For studies with prevalence estimates of 
DED by symptoms and signs and those by symp-
toms, more than half received scores of 10 or 9. 
The detailed assessment of study quality can be 
found in Table S4 in Online Supplementary 
Document.
Prevalence of DED by symptoms 
and signs
Meta-analysis and meta-regression
Meta-analysis of the 24 studies reporting the 
prevalence of DED by symptoms and signs re-
vealed significantly high heterogeneity between 
studies (I2 = 99.3%, P < 0.001). Therefore ran-
dom-effects model was adopted, as shown in 
Figure S2 in Online Supplementary Document, 
the pooled prevalence of DED by symptoms and 
signs was 18.48% (95% CI = 14.76-22.88) from 
the included 24 studies. According to the leave-
one-out sensitivity analysis (Figure S3 in Online 
Supplementary Document), the pooled preva-
lence of DED by symptoms and signs varied from 
17.76% (95% CI = 14.14-22.06) to 19.30% (95% 
CI = 14.44-23.85), no single study significantly 
influenced the liability and stability of the overall 
pooled prevalence in the meta-analysis. Potential publication bias was examined by funnel plot, Egger’s 
test and Begg’s test respectively (Figure S4 in Online Supplementary Document), although the asym-
metrical shape of funnel plot suggested potential publication bias, Egger’s test (t = 0.688, P = 0.498) and 
Begg’s test (z = -0.496, P = 0.620) didn’t reveal a risk of publication bias.
Figure 1. PRISMA of the study selection process.
Table 1. Summary of the main characteristics of the in-
cluded studies
CharaCteristiCs of study
studies with 
prevalenCe of ded by 
symptoms and signs 
(n = 24, %)
studies with 
prevalenCe of ded by 
symptoms  
(n = 13, %)
Year published:
2000-2009 5 (20.83) 7 (53.85)
2010-2016 19 (79.17) 6 (46.15)
Setting:
Urban 12 (50.00) 2 (15.38)
Rural 2 (8.33) 2 (15.38)
Mixed 10 (41.67) 9 (69.23)
Sex:
Both 23 (95.83) 11 (84.62)
Mixed 1 (4.17) 2 (15.38)
Sample size:
300-1000 10 (41.67) 2 (15.38)
1001-2000 3 (12.50) 9 (69.23)
2001-5000 8 (33.33) 1 (7.69)
>5000 3 (12.50) 1 (7.69)
Quality score:
10 9 (37.50) 2 (15.38)
9 7 (29.17) 6 (46.15)
8 0 (0.00) 0 (0.00)
7 2 (8.33) 4 (30.77)
6 6 (25.00) 1 (7.69)
DED – dry eye disease
Dry eye disease prevalence by age, sex and geographic characteristics in China
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In the univariable meta-regression analyses (Table 2), setting (urban vs rural), study year and longitude 
were not significantly associated with the prevalence of DED by symptoms and signs, whereas age, sex 
and latitude were all statistically significant covariates. All significant covariates were then included in the 
subsequent multivariable meta-regression. Diagnostic plots for this meta-regression model are demon-
strated in Figure S5 in Online Supplementary Document.
Estimates of prevalence and cases
The age- and sex-specific prevalence of DED by symptoms and signs was estimated for China and the six 
Chinese regions (Table S5 in Online Supplementary Document). In all the six regions and the whole 
country, the prevalence of DED by symptoms and signs was consistently higher in females than in males, 
and increased steadily with age. By multiplying the corresponding population in 2010, the overall preva-
lence of and the number of people with DED by symptoms and signs in people aged 5-89 years are listed 
in Table 3. In 2010, the overall prevalence of DED by symptoms and signs was 13.55% (95% CI = 10.00-
18.05) in China, and ranged from 8.91% (95% CI = 6.22-12.60) in South Central China to 26.42% (95% 
CI = 17.79-37.25) in Northeast China, which demonstrated a positive trend with increased latitudes. 
The number of people aged 5-89 years that had DED by symptoms and signs was 170.09 million (95% 
CI = 125.52-226.63), and the lowest in Northwest China (16.24 million, 95% CI = 12.50-20.78) and high-
est in East China (45.52 million, 95% CI = 35.77-57.44).
Table 2. Univariable and multivariable meta-regression models of covariates related to the prevalence of DED by 
symptoms and signs*
moderator number of studies number of data points β 95% Ci p-value
Univariable meta-regression:
Intercept 24 112 -1.409 -1.656 to -1.162] <0.001
Age 24 112 0.020 0.018 to 0.022 <0.001
Sex-Male 23 98 -0.252 -0.297 to -0.207] <0.001
Setting-Rural 14 68 0.003 -1.065 to -1.071 0.996
Study year 24 112 0.031 -0.063 to -0.126 0.518
Latitude 24 112 0.056 0.019 to 0.094 0.003
Longitude 24 112 -0.001 -0.023 to 0.022 0.965
Multivariable meta-regression:
Intercept 23 98 -4.708 -6.200 to -3.217] 0.015
Age 23 98 0.020 0.018 to 0.022 <0.001
Sex-Male 23 98 -0.240 -0.285 to -0.195] <0.001
Latitude 23 98 0.073 0.029 to 0.117 0.001
CI – confidence interval
*Coefficients represent log odds ratios (ORs).
Table 3. Sex-specific prevalence and the number of people with DED by symptoms and signs in China and the six Chinese regions in 
2010
region
prevalenCe of ded by symptoms and signs (%, 95% Ci) people with ded by symptoms and signs (million, 95% Ci)
Male Female Overall Male Female Overall
North China 17.81 21.73 19.72 14.23 16.50 30.73
(13.24-23.51) (16.45-28.11) (14.80-25.75) (10.57-18.78) (12.49-21.34) (23.06-40.12)
Northeast China 24.06 28.82 26.42 12.83 15.01 27.84
(15.98-34.48) (19.65-40.08) (17.79-37.25) (8.52-18.39) (10.23-20.87) (18.75-39.25)
East China 10.93 13.68 12.29 20.55 24.97 45.52
(8.52-13.91) (10.82-17.14) (9.65-15.50) (16.01-26.15) (19.75-31.29) (35.77-57.44)
South Central China 7.89 9.99 8.91 14.21 17.10 31.32
(5.46-11.25) (7.01-14.03) (6.22-12.60) (9.84-20.27) (12.00-24.02) (21.84-44.29)
Southwest China 9.06 11.34 10.18 8.39 10.06 18.45
(6.63-12.26) (8.41-15.11) (7.50-13.65) (6.13-11.34) (7.46-13.40) (13.59-24.75)
Northwest China 16.12 19.66 17.84 7.54 8.70 16.24
(12.30-20.82) (15.25-24.95) (13.74-22.83) (5.75-9.74) (6.75-11.04) (12.50-20.78)
China 12.14 15.02 13.55 77.75 92.34 170.09
(8.87-16.34) (11.17-19.84) (10.00-18.05) (56.84-104.67) (68.68-121.96) (125.52-226.63)
Song et al.
December 2018  •  Vol. 8 No. 2 •  020503 6 www.jogh.org •  doi: 10.7189/jogh.08.020503
V
IE
W
PO
IN
TS
RE
SE
A
RC
H
 T
H
E
M
E
 1
: H
E
A
LT
H
  
TR
A
N
SI
TI
O
N
S 
IN
 C
H
IN
A
Prevalence of DED by symptoms
Meta-analysis and meta-regression
As shown in Figure S6 in Online Supplementary Document, significant high heterogeneity existed be-
tween the 13 studies that provided prevalence of DED by symptoms (I2 = 99.7%, P < 0.001). The pooled 
prevalence of DED by symptoms was 38.89% (95% CI = 27.06-52.20) using the random-effects model. 
When removing one single study at one time, the pooled prevalence of DED by symptoms ranged from 
35.80% (95% CI = 25.65-47.40) to 41.70% (95% CI = 31.53-52.63), the liability and stability were not sig-
nificantly influenced (Figure S7 in Online Supplementary Document). Visually inspection of the funnel 
plot suggested potential publication bias, but neither Egger’s test (t = 1.831, P = 0.094) nor Begg’s test (z = 0, 
P = 1.0) significantly indicated any publication bias (Figure S8 in Online Supplementary Document).
Only age was revealed as a significant covariate with the prevalence of DED by symptoms in the univari-
able meta-regression analyses (Table 4). The final meta-regression was constructed by taking the variation 
of age, and the diagnostic plots are shown in Figure S9 in Online Supplementary Document.
Estimates of prevalence and cases
The age-specific prevalence of DED by symptoms is listed in Table S6 in Online Supplementary Doc-
ument, by multiplying the Chinese population data, the overall prevalence of DED by symptoms was 
31.40% (95% CI = 23.02-41.13) in people aged 5-89 years, and the corresponding number of people with 
DED by symptoms was estimated as 394.13 million (95% CI = 288.99-516.30).
Table 4. Univariable and multivariable meta-regression models of covariates related to the prevalence of DED by 
symptoms*
moderator number of studies number of data points β 95% Ci p-value
Univariable meta-regression:
Intercept 13 53 -0.554 -0.987 to -0.122 0.012
Age 13 53 0.026 0.024 to 0.029 <0.001
Sex-Male 11 42 -0.658 -1.836 to 0.521 0.274
Setting-Rural – – – – –
Study year 13 53 0.000 -0.112 to 0.113 0.997
Latitude 13 53 0.064 -0.016 to 0.143 0.116
Longitude 13 53 -0.021 -0.070 to 0.029 0.421
Multivariable meta-regression:
Intercept 13 53 -1.817 -2.277 to -1.356] <0.001
Age 13 53 0.026 0.024-0.029 <0.001
CI – confidence interval
*When insufficient data were available for the comparison between urban and rural settings, it is indicated by “–“.
DISCUSSION
In this study, we presented a comprehensive estimate of DED prevalence in general Chinese population in 
2010 by systematic reviewing all published epidemiological information on DED, and explored its varia-
tions in various groups with different demographic and geographic factors. To date, the variation of defi-
nitions and parameters in the existing studies has restricted the synthesis of DED prevalence to a large ex-
tent, although DED has been widely recognised as a common ocular disorder [16,19,31,39,40]. Our study 
is the second study to generate an overall estimate of DED prevalence in general Chinese population by 
using meta-analysis approach, but it is the first effort to report the prevalence of DED by symptoms and 
signs and DED by symptoms in China separately, which is of both clinical and epidemiological importance.
The merits of our study mainly arise from the comprehensive systematic review approach, which result-
ed in a more than doubled amount of studies in our final analysis than in the study conducted by N Liu, 
et al. [23]. In addition, multiple data points from the same study provided much more information than 
taking only one estimate from each study, our ability to generate estimates of DED prevalence in a broad 
age range was guaranteed. Furthermore, although significant heterogeneity existed between the includ-
ed studies, this high variation may be largely explained by the uneven distribution of various risk factors 
Dry eye disease prevalence by age, sex and geographic characteristics in China
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in investigated sites, such as older age, female sex and low relative humidity [1,12,13,18-21]. Our esti-
mates of DED prevalence were made by taking the significantly associated factors into account, rather 
than simply being pooled together, this measure also largely improved the reliability of our national and 
regional estimates [41,42].
In the current study, we revealed an overall prevalence of DED by symptoms and signs of 13.55% and a 
much higher prevalence of DED by symptoms of 31.40%. Compared with the study conducted by N Liu, 
et al., which reported a pooled DED prevalence of 17.0% by mixing both DED by symptoms and signs 
and DED by symptoms together, it is reasonable to observe a lower prevalence of DED by symptoms and 
signs and a higher prevalence of DED by symptoms in our study [23]. The higher prevalence of DED by 
symptoms generated in this study (31.40% in people aged 5-89 years) than those reported in the United 
States of American (15.2% in adults aged 21 years and above) and England (20.8% in females aged 20 
years and above) confirms the notion that Asians were at a higher risk of DED than Caucasians, as sug-
gested by the TFOS DEWS II Epidemiology Report 2017 [17].
Our study revealed that advanced age was a significant risk factor for both DED by symptoms and signs 
and DED by symptoms, which confirmed the assumption that DED was an age-related disorder, this find-
ing is in line with previous evidence [12,23,43]. The reduction of tear secretion and an increase of evap-
oration with biological ageing may be the core explanation [3,43]. For the prevalence of DED by symp-
toms and signs, female sex was also found to be a positive covariate. The persisted sex difference across 
all ages has also been reported in some previous studies, which might be a combined result of different 
hormonal effects on the ocular surface, lacrimal gland, etc., however, this variation between sexes has 
not become a universally acknowledged notion in previous studies [12,15,44,45], this may be caused by 
different definitions of DED in their investigations, in our study, no sex difference was observed for the 
prevalence of DED by symptoms. More studies are still needed to explore if DED is a more prevalent con-
dition among females, with a focus on different types of DED. In the exploration of geo-epidemiology of 
DED prevalence, increased latitude was found to be a risk factor for DED by symptoms and signs in our 
study, given that low relative humidity is a well-proven risk factor for DED [3,46], the negative relation of 
relative humidity and latitude in China may be the reason for this spatial distribution of DED by symp-
toms and signs [23,47,48]. The absence of a geographic variation of DED by symptoms may be due to 
the limited number of unique study sites, which was only 11. With more epidemiological studies on DED 
emerging, the geo-epidemiology study of DED by symptoms can become possible in the foreseen future.
The large magnitude of DED cases represents a huge public health burden in China, in this study, it was 
estimated that 170.09 million individuals were living with DED by symptoms and signs and 394.13 mil-
lion with DED by symptoms. This figure indicates that the number of Chinese people experiencing symp-
toms of DED in 2010 was even larger than the contemporary overall population in the United States. In 
this modern society where prolonged visual tasking plays an important role in daily activities, the visual 
well-being is especially essential [6,49]. The uncomfortable symptoms together with diminished visual 
performance and quality of life, therefore, represent a huge burden on the whole society and health care 
system [1,50]. With the rapid ageing trend in China, this burden of this age-related condition will pre-
dictably be even larger in the coming years.
Our study also has several potential limitations. First, although a comprehensive systematic review was 
conducted to retrieve all potential studies, all of our included studies were published, the absence of un-
published studies may bring bias in our analyses and final estimates. Second, despite our best efforts to 
minimise variations by applying strict criteria, significant large heterogeneity was still observed among the 
included studies. In meta-regression, only a limited assortment of group-level variables was examined, 
namely, age, sex (male vs female), setting (urban vs rural), study year and geographic indicators (latitude 
and longitude), according to previous studies, the prevalence of DED is especially high in people with 
Sjögren’s syndrome or visual display terminal users, women at perimenopause and postmenopause may 
also be at higher risk of developing DED [6,12,19]. However, because of the lack of available informa-
tion, we could not explore the impact of individual-level variables in our meta-regression approaches. 
Third, the included studies were not from across the whole country, which limited our ability to generate 
estimates of DED prevalence in every single province, therefore we only portrayed an overall picture of 
the DED burden for the whole country, and the six geographic regions at best, regardless of the fact that 
variations may exist within the country or a region. Fourth, latitude was assessed as a significant covariate 
of DED prevalence, to estimate the prevalence and burden of DED in different geographic regions, DED 
cases were calculated based on the Chinese demographic data in 2010, which provided the latest demo-
graphic data stratified by geographic areas. This, however, represents a significant time-lag for assessing 
the latest prevalence and burden of DED in China in 2018.
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CONCLUSIONS
To conclude, our study reveals that DED is a prevalent disorder in the general Chinese population, and 
its impact and importance will grow with the demographic ageing trend. In 2010, the prevalence of DED 
by symptoms and signs were 13.55% and that of DED by symptoms was 31.40% in Chinese people aged 
5-89 years, corresponding to a total of 170.09 million and 394.13 million affected individuals respectively. 
Advanced age, female sex and larger latitude were significant risk factors for DED by symptoms and signs, 
whereas only advanced age was positively associated with an increased prevalence of DED by symptoms. 
The huge burden of DED in China calls for more public health attention and actions. Improved epide-
miological studies on DED prevalence are still needed.
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